As reported, GQD alleviates nonalcoholic steatohepatitis associated liver injuries via anti-inflammatory response and inhibition of toll-like receptor 4 signaling pathways [20]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.